Louisiana Teen Cured of Sickle Cell Anemia After 100 Hospitalizations, 15 Surgeries

**Louisiana Teen Declared Functionally Cured of Sickle Cell Anaemia Following Groundbreaking Gene Therapy**

Fifteen-year-old Phillip Mullin from Alexandria, Louisiana, is celebrating a major milestone in his battle against sickle cell anaemia after being declared functionally cured through the innovative gene therapy known as LYFGENIA. This remarkable development marks Phillip as the first child in the state to achieve such a status, following a life fraught with health challenges.

Phillip has endured more than 100 hospitalisations due to complications related to his condition, which involves the deformity and dysfunction of red blood cells. The young man qualified for the custom stem cell treatment after suffering recurrent pain crises, having undergone a staggering 15 surgical procedures throughout his life. Phillip’s mother, Shataka Figgins, expressed her overwhelming relief and gratitude at a recent celebration held at Manning Family Children’s Hospital on October 23, where doctors confirmed her son’s recovery.

The one-time gene therapy, tailored specifically to each patient using their own stem cells, is approved for individuals aged 12 and up who have documented histories of pain crises. Phillip received his treatment on July 13, coinciding with his sister Paige’s birthday—a day that now holds even greater significance for the family.

Sickle cell anaemia is a genetic disorder that causes red blood cells to take on a sticky, crescent shape, leading to high risks of blockage in blood vessels, strokes, and severe pain. The U.S. Centers for Disease Control and Prevention (CDC) highlights the life-altering complications and intense pain that can accompany the disease.

Phillip’s journey to this triumphant day wasn’t without tribulations. Following his gene therapy infusion, he developed severe mucositis, an inflammation of the mucous membranes that left him needing both a feeding tube and IV pain medication to manage his recovery. Over 100 days post-infusion, Phillip was finally able to celebrate his new health status by ringing the victory bell at Manning Family Children’s Hospital, marking what his doctors described as his highest recorded hemoglobin count.

The joyous event saw the attendance of notable figures, including Archie Manning, a local football legend and hospital namesake, along with Tevin Coleman, an NFL Alumni Ambassador for Genetix, the company responsible for Phillip’s treatment. During his heartfelt speech, Phillip took a moment to honour his sister Paige, whom he affectionately referred to as his superhero, illustrating the strong familial bonds that have supported him through his ordeal.

Prior to his treatment, Phillip visited the Genetix facility in New Jersey, where he witnessed firsthand the process of his cells being transformed into a potential cure. This eye-opening experience has inspired him to pursue a future in paediatric hematology-oncology, as he aims to relate to and support other children facing similar battles.

In a recent interview, Phillip articulated his aspirations, stating, “I want to be a doctor that can relate to somebody, relate to a sickle cell patient and actually know what they’re going through.” His determination reflects a profound understanding of the sacrifices that often accompany medical advancements, as he remarked, “You can’t gain anything without first giving something in return.”

As the Mullin family takes this opportunity to celebrate a new chapter in their lives, Phillip’s story serves as a beacon of hope for other families affected by sickle cell anaemia. Through a blend of innovative medical treatment and unwavering family support, Phillip has demonstrated not only resilience but also an extraordinary spirit that encourages others to face their own challenges head-on.

With eyes set on a promising future, Phillip Mullin embodies the belief that, despite hardship, one can emerge with a heart strong enough to overcome even the most daunting obstacles life may present.